Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 15 of 29
The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence
NCT03575273
Randomized Trial of a Healthy Weight Intervention for Youth With Serious Emotional Disturbance
NCT03075306
Evaluating a Novel Medication Device for Methadone Dosing
NCT03254043
Mindfulness Based Stress Reduction in Rheumatic Diseases
NCT03411057
Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy
NCT03065907
Developing a Dyadic Intervention for Sexually Transmitted Infection (STI)/HIV Prevention in Youth
NCT03275168
Activating Community Support for Substance Users
NCT03194295
Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis
NCT03491267
Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis
NCT03367364
The weWomen and ourCircle Intervention for Immigrant, Refugee and Indigenous Women
NCT03265847
RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain
NCT03305055
Effects of Salvinorin A on Brain Function
NCT03418714
Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT)
NCT02483429
Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
NCT02988401
Autonomic and Cytokines Profiles of Patients With Ulcerative Proctitis
NCT03259659
Effects of Glucocorticoids on Cognition in HIV-infected Women
NCT03237689
Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach
NCT04406467
Pilot of Lifestyle and Asthma Intervention
NCT03291808
Use of MoTrack Therapy in At-Home Hand Rehabilitation
NCT03345693
Sleep and Pain in Sickle Cell Disease
NCT03150433
Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis
NCT03098563
ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study
NCT03082690
Improving Sleep Quality in Heart Failure
NCT03307005
Nasal Continuous Positive Airway Pressure Versus Standard Care During Procedural Sedation for Gastrointestinal Endoscopy
NCT03369197
BREATHE-Easy Trial
NCT03200522
Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU)
NCT03111628
Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis
NCT03185065
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
NCT03270241
A Study of Pregnant and Postpartum Women With and Without Mood Disorders
NCT03615794
Pre-pectoral AlloDerm® to Reinforce Tissues in Tissue Expander Breast Reconstruction
NCT03195322
INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers
NCT02989662
Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin
NCT03289832
Effect of Topical Sulforaphane on Skin Fragility Seen in Skin Aging and With Ultraviolet Exposure
NCT03126539
Brain Imaging of Cannabinoid Receptors
NCT03204305
NanoSpectrometer Biomarker Discovery and Confirmation Study
NCT03275688
Genetic Risk: Whether, When, and How to Tell Adolescents
NCT03421327
Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project)
NCT02674464
Behavioral Economic Purchasing Decisions for Cigarettes of Varied Compositions
NCT02888249
Effects of rhLactoferrin on Chronic Inflammation in the Elderly
NCT02968992
Effects of Psilocybin in Major Depressive Disorder
NCT03181529
Mirabegron For Erectile Dysfunction
NCT02916693
Prospective Clinical Trial of HIV+ Living Donor Kidney Donation for HIV+ Recipients
NCT03408106
Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery
NCT03536065
Intranasal Insulin for the Treatment of HAND
NCT03081117
Cognitive Behavioral Therapy for Insomnia in Substance Use Disorders
NCT03208855
Apixaban Pharmacokinetics in Bariatric Patients (APB)
NCT02406885
Persisting Effects of Psilocybin
NCT02971605
Preventing Falls Among Older Fallers to Test the Effect of LIVE-LiFE, a Home-Based, Tailored Fall Prevention Program
NCT03351413
Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy
NCT00737893
Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients
NCT03088306
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.